PCM
CLBT icon

Penserra Capital Management’s Cellebrite CLBT Stock Holding History

Penserra Capital Management’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,312
Closed -$20K – 1038
2025
Q2 		$20K Buy
+1,312
New +$23.4K ﹤0.01% 798
2024
Q3 		– Sell
-1,160
Closed -$14K – 1133
2024
Q2 		$14K Sell
1,160
-61
-5% -$681 ﹤0.01% 924
2024
Q1 		$13K Buy
+1,221
New +$12.5K ﹤0.01% 921
2022
Q3 		– Sell
-3,392
Closed -$17K – 1019
2022
Q2 		$17K Sell
3,392
-62
-2% -$323 ﹤0.01% 1138
2022
Q1 		$22K Buy
3,454
+644
+23% +$4.27K ﹤0.01% 1231
2021
Q4 		$22K Sell
2,810
-13,026
-82% -$123K ﹤0.01% 1223
2021
Q3 		$146K Buy
+15,836
New +$166K ﹤0.01% 679

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AE
Axon Enterprise Scottsdale, Arizona $19.1M AUM 8.75% 1-Year Est. Return
CCPM
Cooper Creek Partners Management New York $4.21B AUM 44.81% 1-Year Est. Return

Penserra Capital Management's CLBT Position: Q3 2025 in Review

Penserra Capital Management sold out of Cellebrite (CLBT) in Q3 2025, closing a stake of 1,312 shares — an estimated $20K sold.

Penserra Capital Management first reported a position in CLBT in Q3 2021 and held it in 7 quarters. The position peaked at $146K in Q3 2021. 197 funds tracked by Wall St. Rank hold CLBT as of Q3 2025.

  • Penserra Capital Management reported no remaining Cellebrite position as of Q3 2025 after selling out during the quarter.
  • Penserra Capital Management sold 1,312 Cellebrite shares in Q3 2025, an estimated $20K.
  • Penserra Capital Management first reported a position in Cellebrite in Q3 2021 and held it in 7 quarters.
  • Penserra Capital Management's Cellebrite position peaked at $146K in Q3 2021.
  • 197 funds tracked by Wall St. Rank held Cellebrite as of Q3 2025.

Based on Penserra Capital Management's 13F filing for Q3 2025, filed 4 Nov 2025.